Summary
Johnson & Johnson (JNJ) filed an 8-K on April 19, 2011, to report its first-quarter financial results for the period ending April 3, 2011. The filing primarily consists of a press release and supplementary sales data detailing the company's performance. Investors should note that this report serves as the official announcement of these key financial metrics, which would have been closely watched following the quarter's end.
Key Highlights
- 1JNJ announced its first-quarter sales and earnings for the period ending April 3, 2011, via an 8-K filing.
- 2The filing's primary components are a press release and supplementary financial data.
- 3This 8-K serves as the official disclosure of JNJ's Q1 2011 financial performance.
- 4Investors can find detailed sales and earnings information within the attached exhibits.
- 5The report confirms the financial results that were publicly announced on April 19, 2011.
Frequently Asked Questions
The main purpose of this 8-K filing is to formally report Johnson & Johnson's sales and earnings for the first quarter of 2011, which ended on April 3, 2011. It includes the official press release and supplementary financial data.
The detailed financial results, including comparative supplementary sales data and condensed consolidated statements of earnings for the first quarter, are provided as exhibits to this 8-K filing (Exhibit No. 99.15 and 99.20).
This report covers the first quarter of 2011, which ended on April 3, 2011.